Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Net revenue:        
Total revenues $ 14,667 $ 29 $ 22,201 $ 88
Operating expenses:        
Cost of sales 254 0 610 0
Selling, general and administrative 44,128 30,702 127,196 57,204
Research and development 20,066 12,243 39,990 37,154
Amortization of intangible assets 517 316 1,576 902
Other (income) expense, net 55 (917) 859 1,066
Total cost of sales and operating expenses 65,020 42,344 170,231 96,326
Loss from operations (50,353) (42,315) (148,030) (96,238)
Interest income 106 170 420 1,381
Net loss before income taxes (50,247) (42,145) (147,610) (94,857)
Income tax expense (benefit) 8 (15) 34 (251)
Net loss (50,255) (42,130) (147,644) (94,606)
Other comprehensive loss:        
Unrealized (loss) gain on available-for-sale securities, net of tax of nil (2) 0 11 0
Comprehensive loss $ (50,257) $ (42,130) $ (147,633) $ (94,606)
Basic loss per share (expressed in $ per share) $ (0.39) $ (0.34) $ (1.15) $ (0.82)
Diluted loss per share (expressed in $ per share) $ (0.39) $ (0.34) $ (1.15) $ (0.82)
Weighted-average common shares outstanding used in computation of basic loss per share 128,443 122,357 128,084 115,738
Weighted-average common shares outstanding used in computation of diluted loss per share 128,443 122,357 128,084 115,738
Product revenue, net        
Net revenue:        
Total revenues $ 14,638 $ 0 $ 22,113 $ 0
License revenue        
Net revenue:        
Total revenues $ 29 $ 29 $ 88 $ 88